{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:10:19Z","timestamp":1790298619669,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00894-026-06647-1","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:44:37Z","timestamp":1771310677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular docking: a computational approach for the discovery of novel targets against visceral leishmaniasis"],"prefix":"10.1007","volume":"32","author":[{"given":"Vinita","family":"Gouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Kanojia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-2421","authenticated-orcid":false,"given":"Awanish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8735-479X","authenticated-orcid":false,"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"6647_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/14787210.2018.1532790","volume":"16","author":"S Sundar","year":"2018","unstructured":"Sundar S, Singh OP, Chakravarty J (2018) Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence. Expert Rev Anti Infect Ther 16:805\u2013812. https:\/\/doi.org\/10.1080\/14787210.2018.1532790","journal-title":"Expert Rev Anti Infect Ther"},{"key":"6647_CR2","doi-asserted-by":"publisher","unstructured":"Desjeux P, Ghosh RS, Dhalaria P et al (2013) Report of the post Kala-Azar dermal leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27\u201329 June 2012. Parasit Vectors 6. https:\/\/doi.org\/10.1186\/1756-3305-6-196","DOI":"10.1186\/1756-3305-6-196"},{"key":"6647_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/pim.12315","volume":"38","author":"A Kumar","year":"2016","unstructured":"Kumar A, Samant M (2016) DNA vaccine against visceral leishmaniasis: A promising approach for prevention and control. Parasite Immunol 38:273\u2013281. https:\/\/doi.org\/10.1111\/pim.12315","journal-title":"Parasite Immunol"},{"key":"6647_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/ANNUREV.EN.02.010157.001223","volume":"2","author":"S Adler","year":"1957","unstructured":"Adler S, Theodor O (1957) Transmission of disease agents by phlebotomine sand flies. Annu Rev Entomol 2:203\u2013226. https:\/\/doi.org\/10.1146\/ANNUREV.EN.02.010157.001223","journal-title":"Annu Rev Entomol"},{"key":"6647_CR5","doi-asserted-by":"publisher","unstructured":"Mengistu G, Ayele B (2007) Visceral Lieshmaniasis and HIV co-infection in patients admitted to Gondar University Hospital, Northwest Ethiopia. Ethiop J Heal Dev 21. https:\/\/doi.org\/10.4314\/ejhd.v21i1.10032","DOI":"10.4314\/ejhd.v21i1.10032"},{"key":"6647_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/CLEP.S44267","volume":"6","author":"PD Ready","year":"2014","unstructured":"Ready PD (2014) Epidemiology of visceral leishmaniasis. Clin Epidemiol 6:147\u2013154. https:\/\/doi.org\/10.2147\/CLEP.S44267","journal-title":"Clin Epidemiol"},{"key":"6647_CR7","doi-asserted-by":"publisher","unstructured":"Wamai RG, Kahn J, McGloin J, Ziaggi G (2020) Visceral leishmaniasis: a global overview. J Glob Heal Sci 2. https:\/\/doi.org\/10.35500\/jghs.2020.2.e3","DOI":"10.35500\/jghs.2020.2.e3"},{"key":"6647_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1389557517666170425105129","volume":"18","author":"N Tiwari","year":"2017","unstructured":"Tiwari N, Gedda MR, Tiwari VK et al (2017) Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis. Mini-Reviews Med Chem 18:26\u201341. https:\/\/doi.org\/10.2174\/1389557517666170425105129","journal-title":"Mini-Reviews Med Chem"},{"key":"6647_CR9","doi-asserted-by":"publisher","unstructured":"Kumar A, Pandey SC, Samant M (2018) Slow pace of antileishmanial drug development. Parasitol Open 4. https:\/\/doi.org\/10.1017\/pao.2018.1","DOI":"10.1017\/pao.2018.1"},{"key":"6647_CR10","doi-asserted-by":"crossref","unstructured":"Maltezou HC (2010) Drug resistance in visceral leishmaniasis. BioMed Res Int (1):617521","DOI":"10.1155\/2010\/617521"},{"key":"6647_CR11","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/jac\/dkq189","volume":"65","author":"J Kaur","year":"2010","unstructured":"Kaur J, Sundar S, Singh N (2010) Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. J Antimicrob Chemother 65:1742\u20131748. https:\/\/doi.org\/10.1093\/jac\/dkq189","journal-title":"J Antimicrob Chemother"},{"key":"6647_CR12","doi-asserted-by":"crossref","unstructured":"Gouri V, Upreti S, Samant M (2022) Evaluation of target-specific natural compounds for drug discovery against Leishmaniasis. Parasitol Int 91:102622","DOI":"10.1016\/j.parint.2022.102622"},{"key":"6647_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1128\/AAC.00436-10","volume":"55","author":"J Kaur","year":"2011","unstructured":"Kaur J, Kumar P, Tyagi S et al (2011) In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis. Antimicrob Agents Chemother 55:659\u2013666. https:\/\/doi.org\/10.1128\/AAC.00436-10","journal-title":"Antimicrob Agents Chemother"},{"key":"6647_CR14","doi-asserted-by":"crossref","unstructured":"Chawla B, Madhubala R (2010) Drug targets in Leishmania. Journal of parasitic diseases 34(1):1\u201313","DOI":"10.1007\/s12639-010-0006-3"},{"key":"6647_CR15","doi-asserted-by":"publisher","unstructured":"Jain S, Sahu U, Kumar A, Khare P (2022) Metabolic pathways of leishmania parasite: source of pertinent drug targets and potent drug candidates. Pharmaceutics 14. https:\/\/doi.org\/10.3390\/pharmaceutics14081590","DOI":"10.3390\/pharmaceutics14081590"},{"key":"6647_CR16","doi-asserted-by":"publisher","unstructured":"Gouri V, Roy G, Kanojia A et al (2025) Identification of novel inhibitors from Rubus ellipticus as anti \u2011 leishmanial agents targeting DDX3 \u2011 DEAD box RNA helicase of Leishmania donovani. 3 Biotech. https:\/\/doi.org\/10.1007\/s13205-024-04183-4","DOI":"10.1007\/s13205-024-04183-4"},{"key":"6647_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D","volume":"9","author":"DA Gschwend","year":"1996","unstructured":"Gschwend DA, Good AC, Kuntz ID (1996) Molecular docking towards drug discovery. J Mol Recognit 9:175\u2013186. https:\/\/doi.org\/10.1002\/(SICI)1099-1352(199603)9:2%3c175::AID-JMR260%3e3.0.CO;2-D","journal-title":"J Mol Recognit"},{"key":"6647_CR18","doi-asserted-by":"crossref","unstructured":"Gouri V, Pandey SC, Joshi D, Pande V, Upreti S, Samant M (2021) Natural products as a novel source for antileishmanial drug development. In Pathogenesis, Treatment and Prevention of Leishmaniasis pp. 141\u2013159. Academic Press.","DOI":"10.1016\/B978-0-12-822800-5.00011-1"},{"key":"6647_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/J.CSBJ.2016.04.004","volume":"14","author":"T Katsila","year":"2016","unstructured":"Katsila T, Spyroulias GA, Patrinos GP, Matsoukas MT (2016) Computational approaches in target identification and drug discovery. Comput Struct Biotechnol J 14:177\u2013184. https:\/\/doi.org\/10.1016\/J.CSBJ.2016.04.004","journal-title":"Comput Struct Biotechnol J"},{"key":"6647_CR20","doi-asserted-by":"publisher","unstructured":"Singh R, Kashif M, Srivastava P, Manna PP (2023) Recent advances in chemotherapeutics for leishmaniasis: importance of the cellular biochemistry of the parasite and its molecular interaction with the host. Pathogens 12. https:\/\/doi.org\/10.3390\/pathogens12050706","DOI":"10.3390\/pathogens12050706"},{"key":"6647_CR21","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/S12272-015-0640-5","volume":"38","author":"SJY Macalino","year":"2015","unstructured":"Macalino SJY, Gosu V, Hong S, Choi S (2015) Role of computer-aided drug design in modern drug discovery. Arch Pharm Res 38:1686\u20131701. https:\/\/doi.org\/10.1007\/S12272-015-0640-5","journal-title":"Arch Pharm Res"},{"key":"6647_CR22","doi-asserted-by":"publisher","unstructured":"Gouri V, Pandey SC, Joshi D et al (2021) Natural products as a novel source for antileishmanial drug development. Pathog Treat Prev Leishmaniasis 141\u2013159. https:\/\/doi.org\/10.1016\/B978-0-12-822800-5.00011-1","DOI":"10.1016\/B978-0-12-822800-5.00011-1"},{"key":"6647_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/S0033583512000108","volume":"45","author":"A Winter","year":"2012","unstructured":"Winter A, Higueruelo AP, Marsh M et al (2012) Biophysical and computational fragment-based approaches to targeting protein\u2013protein interactions: applications in structure-guided drug discovery. Q Rev Biophys 45:383\u2013426. https:\/\/doi.org\/10.1017\/S0033583512000108","journal-title":"Q Rev Biophys"},{"key":"6647_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/10799893.2016.1171344","volume":"37","author":"RK Pandey","year":"2017","unstructured":"Pandey RK, Kumbhar BV, Sundar S et al (2017) Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. J Recept Signal Transduct 37:60\u201370. https:\/\/doi.org\/10.3109\/10799893.2016.1171344","journal-title":"J Recept Signal Transduct"},{"key":"6647_CR25","unstructured":"Agarwal S, Mehrotra RJJC (2016) An overview of molecular docking. JSM chem 4(2):1024\u20131028"},{"key":"6647_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2","journal-title":"Nature"},{"key":"6647_CR27","doi-asserted-by":"publisher","unstructured":"Tusn\u00e1dy GE, Zeke A, K\u00e1lm\u00e1n ZE et al (2023) Erratum: LeishMANIAdb: a comparative resource for Leishmania proteins (Leishmania proteins, Database (2023).\u00a0https:\/\/doi.org\/10.1093\/database\/baad074)","DOI":"10.1093\/database\/baad074"},{"key":"6647_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00929-7","volume":"16","author":"E Harigua-Souiai","year":"2024","unstructured":"Harigua-Souiai E, Masmoudi O, Makni S et al (2024) cidalsDB: an AI-empowered platform for anti-pathogen therapeutics research. J Cheminform 16:134. https:\/\/doi.org\/10.1186\/s13321-024-00929-7","journal-title":"J Cheminform"},{"key":"6647_CR29","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ijbiomac.2018.10.053","volume":"121","author":"SC Pandey","year":"2019","unstructured":"Pandey SC, Jha A, Kumar A, Samant M (2019) Evaluation of antileishmanial potential of computationally screened compounds targeting DEAD-box RNA helicase of Leishmania donovani. Int J Biol Macromol 121:480\u2013487. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.10.053","journal-title":"Int J Biol Macromol"},{"key":"6647_CR30","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1080\/07391102.2022.2087103","volume":"41","author":"P Prasanna","year":"2023","unstructured":"Prasanna P, Joshi T, Pant M et al (2023) Evaluation of the inhibitory potential of Valproic acid against histone deacetylase of Leishmania donovani and computational studies of Valproic acid derivatives. J Biomol Struct Dyn 41:5447\u20135464. https:\/\/doi.org\/10.1080\/07391102.2022.2087103","journal-title":"J Biomol Struct Dyn"},{"key":"6647_CR31","doi-asserted-by":"publisher","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. academic.oup.com 46. https:\/\/doi.org\/10.1093\/nar\/gky427","DOI":"10.1093\/nar\/gky427"},{"key":"6647_CR32","doi-asserted-by":"publisher","unstructured":"Yang J, Yan R, Roy A et al (2014) The I-TASSER Suite: protein structure and function prediction. nature.comJ Yang, R Yan, A Roy, D Xu, J Poisson Y ZhangNature methods, 2015\u2022nature.com 12:7\u20138. https:\/\/doi.org\/10.1038\/NMETH.3213","DOI":"10.1038\/NMETH.3213"},{"key":"6647_CR33","doi-asserted-by":"publisher","unstructured":"Webb B, bioinformatics AS-C protocols (2016) Comparative protein structure modeling using MODELLER. Wiley Online Libr Webb, A SaliCurrent Protoc bioinformatics. Wiley Online Libr 2016:5.6.1\u20135.6.37. https:\/\/doi.org\/10.1002\/CPBI.3","DOI":"10.1002\/CPBI.3"},{"key":"6647_CR34","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1093\/bioinformatics\/btv411","volume":"31","author":"ED L\u00f3pez","year":"2015","unstructured":"L\u00f3pez ED, Arcon JP, Gauto DF et al (2015) WATCLUST: a tool for improving the design of drugs based on protein-water interactions. Bioinformatics 31:3697\u20133699. https:\/\/doi.org\/10.1093\/bioinformatics\/btv411","journal-title":"Bioinformatics"},{"key":"6647_CR35","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1080\/07391102.2017.1366947","volume":"36","author":"VM V","year":"2018","unstructured":"V VM, Dubey VK, Ponnuraj K (2018) Identification of two natural compound inhibitors of Leishmania donovani spermidine synthase (SpdS) through molecular docking and dynamic studies. J Biomol Struct Dyn 36:2678\u20132693. https:\/\/doi.org\/10.1080\/07391102.2017.1366947","journal-title":"J Biomol Struct Dyn"},{"key":"6647_CR36","doi-asserted-by":"publisher","unstructured":"Gupta PP, Bastikar VA, Chhajed SS (2018) Chemical Structure Databases in Drug Discovery. igi-global.com 47\u201361. https:\/\/doi.org\/10.4018\/978-1-5225-7326-5.ch002","DOI":"10.4018\/978-1-5225-7326-5.ch002"},{"key":"6647_CR37","unstructured":"Craik D (1997). Guidebook on molecular modeling in drug design. Edited by NC Cohen (Pharmaceutical Division of Ciba-Geigy Ltd, Basel) Academic Press: New York"},{"key":"6647_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7324\/JAPS.2017.70924","volume":"7","author":"S Rana","year":"2017","unstructured":"Rana S, Mahato JP, Kumar M, Sarsaiya S (2017) Modeling and docking of Cysteine Protease-A (CPA) of Leishmania donovani. J Appl Pharm Sci 7:179\u2013184. https:\/\/doi.org\/10.7324\/JAPS.2017.70924","journal-title":"J Appl Pharm Sci"},{"key":"6647_CR39","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1007\/s00894-012-1508-y","volume":"18","author":"S Sahi","year":"2012","unstructured":"Sahi S, Tewatia P, Ghosal S (2012) Leishmania donovani pteridine reductase 1: comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum. J Mol Model 18:5065\u20135073. https:\/\/doi.org\/10.1007\/s00894-012-1508-y","journal-title":"J Mol Model"},{"key":"6647_CR40","doi-asserted-by":"publisher","unstructured":"Morris GM, Ruth H, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Wiley Online Libr Morris, R Huey, W Lindstrom, MF Sanner, RK Belew, DS Goodsell, AJ OlsonJournal Comput Chem 2009\u2022Wiley Online Libr 30:2785\u20132791. https:\/\/doi.org\/10.1002\/JCC.21256","DOI":"10.1002\/JCC.21256"},{"key":"6647_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/JCC.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/JCC.21334","journal-title":"J Comput Chem"},{"key":"6647_CR42","doi-asserted-by":"crossref","unstructured":"Bhowmik D, Jagadeesan R, Rai P et al (2021) Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Leishmania donovani nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches. Taylor & Francis","DOI":"10.1080\/07391102.2020.1739557"},{"key":"6647_CR43","doi-asserted-by":"publisher","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. ACS Publ Friesner, JL Banks, RB Murphy, TA Halgren, JJ Klicic, DT Mainz, MP Repasky, EH KnollJournal Med Chem 2004\u2022ACS Publ 47:1739\u20131749. https:\/\/doi.org\/10.1021\/JM0306430","DOI":"10.1021\/JM0306430"},{"key":"6647_CR44","doi-asserted-by":"publisher","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. ACS Publ Halgren, RB Murphy, RA Friesner, HS Beard, LL Frye, WT Pollard, JL BanksJournal Med Chem 2004\u2022ACS Publ 47:1750\u20131759. https:\/\/doi.org\/10.1021\/JM030644S","DOI":"10.1021\/JM030644S"},{"key":"6647_CR45","doi-asserted-by":"publisher","unstructured":"Tuccinardi T, Poli G, Romboli V et al (2014) Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies. ACS Publ Tuccinardi, G Poli, V Romboli, A Giordano, A MartinelliJournal Chem Inf Model 2014\u2022ACS Publ 54:2980\u20132986. https:\/\/doi.org\/10.1021\/CI500424N","DOI":"10.1021\/CI500424N"},{"key":"6647_CR46","doi-asserted-by":"publisher","first-page":"35383","DOI":"10.1039\/d1ra05785e","volume":"11","author":"V Scardino","year":"2021","unstructured":"Scardino V, Bollini M, Cavasotto CN (2021) Combination of pose and rank consensus in docking-based virtual screening: the best of both worlds. RSC Adv 11:35383\u201335391. https:\/\/doi.org\/10.1039\/d1ra05785e","journal-title":"RSC Adv"},{"key":"6647_CR47","doi-asserted-by":"publisher","unstructured":"Ghasemi JB, Abdolmaleki A, Shiri F (2016) Molecular Docking Challenges and Limitations. Pharm Sci 770\u2013794. https:\/\/doi.org\/10.4018\/978-1-5225-1762-7.ch030","DOI":"10.4018\/978-1-5225-1762-7.ch030"},{"key":"6647_CR48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/jac\/dkn319","volume":"62","author":"P Misra","year":"2008","unstructured":"Misra P, Khaliq T, Dixit A et al (2008) Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design. J Antimicrob Chemother 62:998\u20131002. https:\/\/doi.org\/10.1093\/jac\/dkn319","journal-title":"J Antimicrob Chemother"},{"key":"6647_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/BIOF.5520270110","volume":"27","author":"T Jaeger","year":"2006","unstructured":"Jaeger T, Flohe L (2006) The thiol-based redox networks of pathogens: unexploited targets in the search for new drugs. BioFactors 27:109\u2013120. https:\/\/doi.org\/10.1002\/BIOF.5520270110","journal-title":"BioFactors"},{"key":"6647_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jmgm.2013.12.010","volume":"48","author":"IV Ogungbe","year":"2014","unstructured":"Ogungbe IV, Erwin WR, Setzer WN (2014) Antileishmanial phytochemical phenolics: molecular docking to potential protein targets. J Mol Graph Model 48:105\u2013117. https:\/\/doi.org\/10.1016\/j.jmgm.2013.12.010","journal-title":"J Mol Graph Model"},{"key":"6647_CR51","doi-asserted-by":"crossref","unstructured":"Comini MA, Krauth-Siegel RL, Bellanda M (2013) Mono-and dithiol glutaredoxins in the trypanothione-based redox metabolism of pathogenic trypanosomes. Antioxid Redox Signal 19(7):708\u2013722","DOI":"10.1089\/ars.2012.4932"},{"key":"6647_CR52","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1126\/science.3883489","volume":"227","author":"AH Fairlamb","year":"1985","unstructured":"Fairlamb AH, Blackburn P, Ulrich P et al (1985) Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 227:1485\u20131487. https:\/\/doi.org\/10.1126\/science.3883489","journal-title":"Science"},{"key":"6647_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/092986609787316306","volume":"16","author":"P Baiocco","year":"2009","unstructured":"Baiocco P, Franceschini S, Ilari A, Colotti G (2009) Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis. Protein Pept Lett 16:196\u2013200. https:\/\/doi.org\/10.2174\/092986609787316306","journal-title":"Protein Pept Lett"},{"key":"6647_CR54","doi-asserted-by":"publisher","unstructured":"Ilari A, Baiocco P, Messori L et al (2012) A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin. SpringerA Ilari, P Baiocco, L Messori, A Fiorillo, A Boffi, M Gramiccia, T Di Muccio, G ColottiAmino acids, 2012\u2022Springer 42:803\u2013811. https:\/\/doi.org\/10.1007\/S00726-011-0997-9","DOI":"10.1007\/S00726-011-0997-9"},{"key":"6647_CR55","doi-asserted-by":"publisher","unstructured":"Baiocco P, Poce G, Alfonso S et al (2013) Inhibition of Leishmania infantum Trypanothione Reductase by Azole\u2010Based Compounds: a Comparative Analysis with Its Physiological Substrate by X\u2010ray. Wiley Online Libr Baiocco, G Poce, S Alfonso, M Cocozza, GC Porretta, G Colotti, M Biava, F MoracaChemMedChem, 2013\u2022Wiley Online Libr 8:1175\u20131183. https:\/\/doi.org\/10.1002\/CMDC.201300176","DOI":"10.1002\/CMDC.201300176"},{"key":"6647_CR56","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/JCC.21538","volume":"31","author":"SK Venkatesan","year":"2010","unstructured":"Venkatesan SK, Shukla AK, Dubey VK (2010) Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum. J Comput Chem 31:2463\u20132475. https:\/\/doi.org\/10.1002\/JCC.21538","journal-title":"J Comput Chem"},{"key":"6647_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12539-011-0101-x","volume":"3","author":"SK Venkatesan","year":"2011","unstructured":"Venkatesan SK, Saudagar P, Shukla AK, Dubey VK (2011) Screening natural products database for identification of potential antileishmanial chemotherapeutic agents. Interdiscip Sci \u2013 Comput Life Sci 3:217\u2013231. https:\/\/doi.org\/10.1007\/s12539-011-0101-x","journal-title":"Interdiscip Sci \u2013 Comput Life Sci"},{"key":"6647_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.640561","volume":"11","author":"JDF Inacio","year":"2021","unstructured":"Inacio JDF, Fonseca MS, Limaverde-Sousa G et al (2021) Epigallocathechin-O-3-Gallate inhibits trypanothione reductase of Leishmania infantum, causing alterations in redox balance and leading to parasite death. Front Cell Infect Microbiol 11:1\u201311. https:\/\/doi.org\/10.3389\/fcimb.2021.640561","journal-title":"Front Cell Infect Microbiol"},{"key":"6647_CR59","doi-asserted-by":"crossref","unstructured":"Reguera RM, Elmahallawy EK, Garc\u00eda-Estrada C et al (2019) DNA topoisomerases of Leishmania parasites; druggable targets for drug discovery. Curr Med Chem 26(32):5900\u20135923","DOI":"10.2174\/0929867325666180518074959"},{"key":"6647_CR60","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1021\/JM049146P","volume":"48","author":"BL Staker","year":"2005","unstructured":"Staker BL, Feese MD, Cushman M et al (2005) Structures of three classes of anticancer agents bound to the human topoisomerase I\u2212 DNA covalent complex. J Med Chem 48:2336\u20132345. https:\/\/doi.org\/10.1021\/JM049146P","journal-title":"J Med Chem"},{"key":"6647_CR61","doi-asserted-by":"crossref","unstructured":"Bienert S, Waterhouse A, De Beer TA et al (2017) The SWISS-MODEL Repository\u2014new features and functionality. Nucleic acids res 45(D1):D313\u2013D319","DOI":"10.1093\/nar\/gkw1132"},{"key":"6647_CR62","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/NAR\/GKY427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/NAR\/GKY427","journal-title":"Nucleic Acids Res"},{"key":"6647_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijpddr.2019.10.004","volume":"11","author":"Y P\u00e9rez-Pertejo","year":"2019","unstructured":"P\u00e9rez-Pertejo Y, Escudero-Mart\u00ednez JM, Reguera RM et al (2019) Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB. Int J Parasitol Drugs Drug Resist 11:70\u201379. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.10.004","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"6647_CR64","doi-asserted-by":"publisher","first-page":"14640","DOI":"10.1021\/acsomega.9b02130","volume":"4","author":"S Chandra Pandey","year":"2019","unstructured":"Chandra Pandey S, Dhami DS, Jha A et al (2019) Identification of trans-2-cis-8-matricaria-ester from the essential oil of Erigeron multiradiatus and evaluation of its antileishmanial potential by in vitro and in silico approaches. ACS Omega 4:14640\u201314649. https:\/\/doi.org\/10.1021\/acsomega.9b02130","journal-title":"ACS Omega"},{"key":"6647_CR65","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1128\/AAC.00352-16","volume":"60","author":"S Saha","year":"2016","unstructured":"Saha S, Acharya C, Pal U et al (2016) A novel spirooxindole derivative inhibits the growth of leishmania donovani parasites both in vitro and in vivo by targeting type IB topoisomerase. Antimicrob Agents Chemother 60:6281\u20136293. https:\/\/doi.org\/10.1128\/AAC.00352-16","journal-title":"Antimicrob Agents Chemother"},{"key":"6647_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/BSE0510063","volume":"51","author":"TJ Vickers","year":"2011","unstructured":"Vickers TJ, Beverley SM (2011) Folate metabolic pathways in Leishmania. Essays Biochem 51:63\u201380. https:\/\/doi.org\/10.1042\/BSE0510063","journal-title":"Essays Biochem"},{"key":"6647_CR67","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/s0031182097001133","volume":"114","author":"B Nare","year":"1997","unstructured":"Nare B, Luba J, Hardy LW, Beverley S (1997) New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology 114:101\u2013110. https:\/\/doi.org\/10.1017\/s0031182097001133","journal-title":"Parasitology"},{"key":"6647_CR68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1371\/journal.pntd.0000729","volume":"4","author":"W-L Yau","year":"2010","unstructured":"Yau W-L, Blisnick T, Taly J-F et al (2010) Cyclosporin A treatment of Leishmania donovani reveals stage-specific. PLoS Neglected Trop Dis Public Libr Sci 4:4. https:\/\/doi.org\/10.1371\/journal.pntd.0000729","journal-title":"PLoS Neglected Trop Dis Public Libr Sci"},{"key":"6647_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23040772","volume":"23","author":"S Stevanovi\u0107","year":"2018","unstructured":"Stevanovi\u0107 S, Perdih A, Sen\u0107anski M et al (2018) In silico discovery of a substituted 6-Methoxy-quinalidine with leishmanicidal activity in Leishmania infantum. Molecules 23:1\u201316. https:\/\/doi.org\/10.3390\/molecules23040772","journal-title":"Molecules"},{"key":"6647_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.3021","volume":"36","author":"SY Sheikh","year":"2023","unstructured":"Sheikh SY, Ansari WA, Hassan F et al (2023) Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis. J Mol Recognit 36:e3021. https:\/\/doi.org\/10.1002\/jmr.3021","journal-title":"J Mol Recognit"},{"key":"6647_CR71","doi-asserted-by":"publisher","first-page":"16159","DOI":"10.1021\/ACS.JMEDCHEM.1C01437\/SUPPL_FILE\/JM1C01437_SI_004.PDB","volume":"64","author":"CE Mowbray","year":"2021","unstructured":"Mowbray CE, Braillard S, Glossop PA et al (2021) DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. J Med Chem 64:16159\u201316176. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.1C01437\/SUPPL_FILE\/JM1C01437_SI_004.PDB","journal-title":"J Med Chem"},{"key":"6647_CR72","doi-asserted-by":"crossref","unstructured":"Padmanabhan PK, Zghidi-Abouzid O, Samant M et al (2016) DDX3 DEAD-box RNA helicase plays a central role in mitochondrial protein quality control in Leishmania. nature.com 7:2406\u20132406","DOI":"10.1038\/cddis.2016.315"},{"key":"6647_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/JBB\/2006\/13474","volume":"2006","author":"M Ouaissi","year":"2006","unstructured":"Ouaissi M, Ouaissi A (2006) Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases. J Biomed Biotechnol 2006:1\u201310. https:\/\/doi.org\/10.1155\/JBB\/2006\/13474","journal-title":"J Biomed Biotechnol"},{"key":"6647_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07178","volume":"7","author":"PM Wadanambi","year":"2021","unstructured":"Wadanambi PM, Mannapperuma U (2021) Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from Leishmania donovani. Heliyon 7:e07178. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07178","journal-title":"Heliyon"},{"key":"6647_CR75","doi-asserted-by":"publisher","unstructured":"Orabi MAA, Alshahrani MM, Sayed AM et al (2023) Identification of Potential Leishmania N-Myristoyltransferase Inhibitors from Withania somnifera (L.) Dunal: A Molecular Docking and Molecular Dynamics Investigation. Metabolites 13. https:\/\/doi.org\/10.3390\/metabo13010093","DOI":"10.3390\/metabo13010093"},{"key":"6647_CR76","doi-asserted-by":"crossref","unstructured":"Grover A, Katiyar SP, Jeyakanthan J et al (2012) Blocking Protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera. BMC genomics 13(Suppl 7):S20","DOI":"10.1186\/1471-2164-13-S7-S20"},{"key":"6647_CR77","doi-asserted-by":"publisher","unstructured":"Sharma U, Velpandian T (2009) Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties. 1287\u20131293. https:\/\/doi.org\/10.1007\/s00436-009-1554-2","DOI":"10.1007\/s00436-009-1554-2"},{"key":"6647_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.01278","volume":"9","author":"LLG Ferreira","year":"2018","unstructured":"Ferreira LLG, Andricopulo AD (2018) Chemoinformatics strategies for leishmaniasis drug discovery. Front Pharmacol 9:1\u201311. https:\/\/doi.org\/10.3389\/fphar.2018.01278","journal-title":"Front Pharmacol"},{"key":"6647_CR79","doi-asserted-by":"publisher","unstructured":"Alamzeb M, Ali S, Mamoon-Ur-Rashid et al (2021) Antileishmanial Potential of Berberine Alkaloids From Berberis glaucocarpa Roots: Molecular Docking Suggests Relevant Leishmania Protein Targets. Nat Prod Commun 16. https:\/\/doi.org\/10.1177\/1934578X211031148","DOI":"10.1177\/1934578X211031148"},{"key":"6647_CR80","doi-asserted-by":"publisher","unstructured":"Sakyi PO, Kwofie SK, Tuekpe JK et al (2023) Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. mdpi.comPO Sakyi, SK Kwofie, JK Tuekpe, TM Gwira, E Broni, WA Mill III, MD Wilson, RK AmewuPharmaceuticals, 2023\u2022mdpi.com 16. https:\/\/doi.org\/10.3390\/PH16030330","DOI":"10.3390\/PH16030330"},{"key":"6647_CR81","doi-asserted-by":"publisher","unstructured":"Jain S, Sahu U, Kumar A, Khare P (2022) Metabolic pathways of leishmania parasite: source of pertinent drug targets and potent drug candidates. mdpi.comS Jain, U Sahu, A Kumar, P KharePharmaceutics, 2022\u2022mdpi.com 14. https:\/\/doi.org\/10.3390\/PHARMACEUTICS14081590","DOI":"10.3390\/PHARMACEUTICS14081590"},{"key":"6647_CR82","doi-asserted-by":"publisher","unstructured":"Goto Y, Bhatia A, Raman VS et al (2009) Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection. ElsevierY Goto, A Bhatia, VS Raman, SEZ Vidal, S Bertholet, RN Coler RF Howard, SG ReedVaccine, 2009\u2022Elsevier 27:2884\u20132890. https:\/\/doi.org\/10.1016\/J.VACCINE.2009.02.079","DOI":"10.1016\/J.VACCINE.2009.02.079"},{"key":"6647_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45448-x","volume":"13","author":"K Bora","year":"2023","unstructured":"Bora K, Sarma M, Kanaujia SP, Dubey VK (2023) Dual-target drugs against Leishmania donovani for potential novel therapeutics. Sci Rep 13:18363. https:\/\/doi.org\/10.1038\/s41598-023-45448-x","journal-title":"Sci Rep"},{"key":"6647_CR84","doi-asserted-by":"publisher","unstructured":"Chibli LA, Schmidt TJ, Nonato MC et al (2018) Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. ElsevierLA Chibli, TJ Schmidt, MC Nonato, FA Calil, FB Da CostaEuropean J Med Chem 2018\u2022Elsevier 157:852\u2013866. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.08.033","DOI":"10.1016\/J.EJMECH.2018.08.033"},{"key":"6647_CR85","doi-asserted-by":"crossref","unstructured":"Padmanabhan PK, Samant M, Cloutier S et al (2012) Apoptosis-like programmed cell death induces antisense ribosomal RNA (rRNA) fragmentation and rRNA degradation in Leishmania. Cell Death Differ 19:1972\u20131982","DOI":"10.1038\/cdd.2012.85"},{"key":"6647_CR86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exppara.2004.04.002","volume":"106","author":"CD Giorgio","year":"2004","unstructured":"Giorgio CD, Delmas F, Ollivier E et al (2004) In vitro activity of the b -carboline alkaloids harmane , harmine , and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol 106:67\u201374. https:\/\/doi.org\/10.1016\/j.exppara.2004.04.002","journal-title":"Exp Parasitol"},{"key":"6647_CR87","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1055\/s-2006-959737","volume":"59","author":"A Kapil","year":"1993","unstructured":"Kapil A (1993) Piperine: A potent inhibitor of Leishmania donovani promastigotes in vitro. Planta Med 59:474. https:\/\/doi.org\/10.1055\/s-2006-959737","journal-title":"Planta Med"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06647-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-06647-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06647-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:09:28Z","timestamp":1772842168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-026-06647-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6647"],"URL":"https:\/\/doi.org\/10.1007\/s00894-026-06647-1","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}